Shifts in the human gut microbiome during cancer chemotherapy are diet-dependent.
Ontology highlight
ABSTRACT: Numerous studies have implicated both dietary intake and the human gut microbiome in colorectal cancer (CRC) treatment outcomes. However, little is known about how patients adjust their dietary intake during cancer chemotherapy or if these dietary changes contribute to treatment-associated alterations in the gut microbiome. We performed paired longitudinal diet and microbiome analysis during CRC treatment with oral fluoropyrimidines (NCT04054908) and validated key associations using cell culture assays. Diet quality significantly decreased during chemotherapy. Carbohydrate and refined grain intake increased, accompanied by decreased consumption of fats, nuts and seeds, and fat-soluble micronutrients. Multiple individual dietary components were strongly linked to the gut microbiome. Decreas
SUBMITTER: Trepka KR
PROVIDER: S-EPMC12767648 | biostudies-literature | 2025 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA